The UHS Heart & Vascular Institute recently reached a significant milestone of experience and trust—completing its 1,000th TAVR (Transcatheter Aortic Valve Replacement) procedure. More than just a number, this achievement represents improved lives for patients with aortic valve stenosis. For Barbara McDevitt, the 1,000th TAVR patient, it meant continuing her active, healthy lifestyle.
Ms. McDevitt received annual echocardiograms to monitor her heart. In June 2024, results showed severe aortic valve stenosis, a condition that restricts blood flow from the heart to the body. Because she had never experienced any symptoms, she was shocked. Symptoms can include chest pain, breathlessness and fatigue, particularly with activity.
“I had been in the moderate stage for years, so hearing it was now severe was scary,” Ms. McDevitt said.
A minimally invasive option
Ms. McDevitt’s provider referred her to Alon Yarkoni, MD, FACC, director of the Structural Heart Program, UHS Heart and Vascular Institute. Unlike open-heart surgery, TAVR replaces the diseased valve using a catheter inserted through a small incision in the groin, making it a less invasive alternative.
The procedure is a team effort, involving cardiologists, heart surgeons, nurses, radiology technicians and anesthesiologists. From pre-op to discharge, dedicated staff ensure smooth recovery.
Despite initial hesitation, Ms. McDevitt discussed her concerns with UHS Clinic Coordinator Nicole Schneider, RN. Ms. Schneider thoroughly explained the process, easing Ms. McDevitt’s fears and helping her decide to proceed.
“I didn’t feel sick, so it was difficult to decide. But after learning more, I realized it was best to do it now rather than wait for an emergency,” Ms. McDevitt said.
Reassurance and recovery
The morning of the procedure, Ms. Schneider stopped by to reassure Ms. McDevitt. “I was nervous, but her kindness and understanding made a difference,” she said. The 45-minute surgery went smoothly, and she was discharged the next afternoon.
Post-procedure, UHS Cardiology Nurse Practitioner Kristen Lewis, FNP, managed Ms. McDevitt’s recovery, prescribing a three-month course of Plavix and daily low-dose aspirin to prevent blood clots. Most TAVR patients continue aspirin long-term to reduce heart attack and stroke risks.
Thriving after TAVR
A follow-up echocardiogram confirmed her new valve was working well. “Kristen was always informative, reassuring and took the time to answer all my questions,” Ms. McDevitt said.
She remains active, enjoying family time, cooking and walking. “I never stopped doing what I loved, but now I plan to be even more diligent about staying active.”
Ms. McDevitt was grateful to be part of this milestone. “Knowing Dr. Yarkoni had done so many procedures gave me confidence. This milestone reflects the trust patients have in his expertise.”
1,000 procedures strong
UHS performed the Greater Binghamton region’s first TAVR in 2014 at Wilson Medical Center. Now at 1,000 procedures, the program is a testament to expert care in the Greater Binghamton area.
“TAVR has transformed lives in our community. I’m proud of our team for making this a successful program,” said Dr. Yarkoni.
Since performing the first TAVR in 2014, UHS continues to lead the way in expert, life-changing heart care for the Greater Binghamton region.
Learn more
Learn more about the TAVR procedure and the UHS Heart and Vascular Institute at nyuhs.org.
